See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621221_2024_Artelo_Biosciences_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001621221, Artelo Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,980,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,039,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 24,000 |
| 4 | LiabilitiesCurrent | 1,291,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,928,589 |
| 9 | ResearchAndDevelopmentExpense | 6,156,808 |
| 10 | remainder_Expenses | -477,200 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,658,762 |
| 13 | remainder_ComprehensiveNetIncome | 23,779 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,043,000 |
| 1 | Liabilities | 1,291,000 |
| 2 | Expenses | 10,608,197 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 11,752,000 |
| 5 | NetIncome | -8,949,435 |
| 6 | ComprehensiveNetIncome | -8,937,546 |
| 7 | BaseVar | 13,312,369 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.33 |
| 9 | EconomicCapitalRatio | 3.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
